Australia Digital Diabetes Management Market, 2026-2033
- MedTech
- Diabetes Care
- digital diabetes management market
- Diabetes Care
Global Market
Related Markets
Ask a question about the digital diabetes management market
Australia digital diabetes management market highlights
- The Australia digital diabetes management market generated a revenue of USD 303.8 million in 2025 and is expected to reach USD 677.2 million by 2033.
- The Australia market is expected to grow at a CAGR of 10.8% from 2026 to 2033.
- In terms of segment, continuous glucose monitoring systems was the largest revenue generating product in 2025.
- Smart Insulin Pens is the most lucrative product segment registering the fastest growth during the forecast period.
Digital diabetes management market data book summary
| Market revenue in 2025 | USD 303.8 million |
| Market revenue in 2033 | USD 677.2 million |
| Growth rate | 10.8% (CAGR from 2026 to 2033) |
| Largest segment | Continuous glucose monitoring systems |
| Fastest growing segment | Smart Insulin Pens |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed Loop Systems, Apps |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders |
Other key industry trends
- In terms of revenue, Australia accounted for 2.1% of the global digital diabetes management market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China digital diabetes management market is projected to lead the regional market in terms of revenue in 2033.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,860.7 million by 2033.
According to the Australian Bureau of Statistics, there were an estimated 1.2 million people living with diabetes in 2017. Several government initiatives are expected to propel the market over the forecast period. For instance, the Australian National Diabetes Strategy 2016-2020 was formed to outline Australia’s national response to diabetes and the utilization of existing limited resources in a better way.
Furthermore, the Australian government is subsidizing CGM products for diabetes patients across Australia. In 2016, the Federal election in the Government of Australia committed to subsidizing CGM technology to assist young adults and children under 21 years of age who are suffering from type 1 diabetes.
Diabetes Australia now provides access to subsidized CGM products through the National Diabetes Service Schemes (NDSS). The market is further propelled by technological advancements in diabetes devices in the region. Currently, Dexcom G5, Minimed 640, Medtronic 670G, and Guardian Connect CGM systems are some of the key products available in the market.
No credit card required*
Publish Date: Jun 11, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Diabetes Management Market
Digital Diabetes Management Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Insulet Corp | View profile | 3,000 | 100 Nagog Park, Acton, MA, United States, 01720 | www.insulet.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | www.bbraunusa.com |
| PHC Holdings Corp | View profile | 11,897 | 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, 105-8433 | www.phchd.com |
| DexCom Inc | View profile | 9,600 | 6340 Sequence Drive, San Diego, CA, United States, 92121 | www.dexcom.com |
| Brigade High Income Founders | View profile | - | - | - |
Australia digital diabetes management market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Diabetes Management Market will help companies and investors design strategic landscapes.
Continuous Glucose Monitoring Systems was the largest segment with a revenue share of 43.84% in 2025.
Horizon Databook has segmented the Australia digital diabetes management market based on smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps/closed loop systems, apps covering the revenue growth of each sub-segment from 2021 to 2033.
According to the Australian Bureau of Statistics, there were an estimated 1.2 million people living with diabetes in 2017. Several government initiatives are expected to propel the market over the forecast period. For instance, the Australian National Diabetes Strategy 2016-2020 was formed to outline Australia’s national response to diabetes and the utilization of existing limited resources in a better way.
Furthermore, the Australian government is subsidizing CGM products for diabetes patients across Australia. In 2016, the Federal election in the Government of Australia committed to subsidizing CGM technology to assist young adults and children under 21 years of age who are suffering from type 1 diabetes.
Diabetes Australia now provides access to subsidized CGM products through the National Diabetes Service Schemes (NDSS). The market is further propelled by technological advancements in diabetes devices in the region. Currently, Dexcom G5, Minimed 640, Medtronic 670G, and Guardian Connect CGM systems are some of the key products available in the market.
- Australia Digital Diabetes Management Market Product Outlook (Revenue, USD Million , 2021-2033)
- Smart Glucose Meters
- Continuous Glucose Monitoring Systems
- Smart Insulin Pens
- Smart Insulin Pumps/Closed Loop Systems
- Apps
- Australia Digital Diabetes Management Market Type Outlook (Revenue, USD Million , 2021-2033)
- Wearable Devices
- Hand Held Devices
Reasons to subscribe to digital diabetes management market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of digital diabetes management market databook
- Our clientele includes a mix of digital diabetes management market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia digital diabetes management market, including forecasts for subscribers. This country databook contains high-level insights into Australia digital diabetes management market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Digital Diabetes Management Market, 2021-2033 (US$M)
Australia Product - Digital Diabetes Management Market, 2025 - 2033 (US$M)
